Abstract:
In The single crystal of indium phosphide (InP) is dark gray in color with a molecular weight of 145.8, and it is important in III-V semiconductors for optoelectronic devices, such as light emitting diodes (LED), photodiodes, laser diodes, solar bat teries, and so on. InP is not soluble in water, but it responds to acid, producing hydrogen, phosphorus and phosphinei '2) .
The in vitro solubility of InP single-crystal chips in synthetic lung fluid (Gamble solution) was in vestigated by Ditter and Fernando3) . They demon strated that In and P were derived from the InP surface by Gamble solution, and that InP was quite insoluble and did not react with water.
The in vivo toxicity of indium compounds depends on their chemical formula and administration route 2). The oral lethal dose 50 (LD50) of metallic indium is 4,200 mg/kg for the rat4), while the in traperitoneal LD50 of indium trichloride is 5 mg/kg for the mouse 5). Indium trichloride induces renal damage and depression of heme metabolism ; colloi dal indium trioxide is hepatotoxic ; and indium ni trate causes digital malformation in the hamster fetus"'). Zheng et al.7 investigated the tissue distri bution and elimination of indium in male rats fol lowing oral and intratracheal administration of InP. Their results indicated that indium was relatively evenly distributed among the major organs, such as the liver, kidneys, lungs, spleen, and testes, and they concluded that indium would not accumulate in the body following InP oral and intratracheal exposure because of its poor absorption of indium.
Despite widespread use of InP, however, there are few toxicity data on it. This study was designed to clarify the in vitro solubility and the in vivo basic toxicity of InP.
Materials and Methods

InP preparation and analysis
Single-crystal InP wafers (99.999% purity, Furu kawa Electric) were powdered in a mortar. The distribution of InP particle size was measured under an optical microscope. More than 75 percent of the particles were 2.4 ,um or less in diameter. The milled particles were used throughout the study.
Indium in the samples was analyzed by graphite furnace atomic absorption spectrometry (GFAAS) (Z-8720, Hitachi)8 . Absorbance was found to be 324.8 nm.
In vitro solubility of InP InP powder (0.5 mg) was put in screw-capped glass tubes containing 5 ml of synthetic gastric fluid, synthetic lung fluid (Gamble solution)9,10) or physiological saline, and then mixed. The tubes were stored in a refrigerator (4'C) or thermostat chamber (37 °C) for from 30 min to 4 wks with oc casional stirring. The solubility of InP was assessed by determining the indium concentration in the su pernatant of the samples by means of GFAAS.
Animals
Four-week-old male ICR mice (SPF grade) were purchased from Nippon SLC and acclimatized for one week. They were housed five to a plastic cage in a filtered air-ventilated rack for animal feeding. The rack was maintained at 24 °C, 60% relative hu midity, and under a 12-h light-dark cycle. The mice were fed pelleted rodent chow (CRF-1, Orien tal Kobo) and distilled water ad libitum.
After acclimatization, 0, 1,000, 3,000, or 5,000 mg/kg of InP particles suspended in 0.3 ml of phys iological saline was administrated orally (p. o.) or intraperitoneally (i. p.). The numbers of mice were 3, 9, 9, and 6 at 0, 1,000, 3,000, and 5,000 mg/kg p. o. of InP, and 4, 9, 9, and 9 at 0, 1,000, 3,000, and 5,000 mg/kg i. p. of InP, respectively. Two 3,000 mg/kg p. o. administered mice were excluded be cause of InP leakage into the endothoracic portion.
Animal observations
The behavior and external appearance of the mice were checked every weekday for 2 wks, and body weight was measured every other day.
Pathological examination
After 2 wks of observation, the mice were anes thetized with phenobarbital, and blood was collected from the inferior abdominal vena. The lungs, liver, kidneys, spleen, and testes were carefully observed, removed and weighed. The organs in the i.p. dosed group that showed a high incidence of gross patho logical findings, were fixed with 10% buffered neu tral formalin, embedded in paraffin, sectioned, and stained with hematoxylin-eosin for pathological study.
Indium concentrations in the organs
In the 0 and 5,000 mg/kg dosed groups, indium concentrations in the lungs, liver, kidneys, and testes were measured by the same GFAAS method as those in synthetic fluids. Serum indium concen trations in all mice were also measured by GFAAS.
Blood analysis
In hematological examinations, total and differen tial white blood cell counts (WBC), red blood cell count (RBC), hemoglobin (Hb), and hematocrit (Hct) were measured . Total protein (TP), albu min (Alb), aspartate aminotransferase (AST), ala nine aminotransferase (ALT), lactate dehydroge nase (LDH), alkaline phosphatase (ALP), blood urea nitrogen (BUN), creatinine (Cre), sodium (Na), potassium (K) and chloride (CI) were deter mined in serum biochemical examinations.
Statistical analysis
Student's t-test or Welch's method were adopted for statistical testing of differences between means of the effect indices. The analysis of pathological findings was performed by Fisher's test.
Results
In vitro solubility Fig. 1 illustrates the solubilities of InP particles expressed as indium concentration in 3 different media. The solubility in synthetic gastric fluid was maximum during the period of four wks, and it was higher at 37'C than those at 4'C, although some variations were observed. The solubilities in saline and Gamble solution were low and showed no time or temperature dependency.
Mortality and animal observations
No mice died during the 2-wk observation period. No clear changes in behavior or external appear ance of InP-administrated mice were observed during the 2 wks, and no differences in behavior or external appearance were found among the 4 groups of mice.
Body and organ weights
Body weight gains during the 2 wks did not differ among the groups (Table 1) . Weight gain in the 5,000 mg/kg i. p. administered mice seemed to be less than in the other groups, but the difference was not significant.
Prominent increases in lung and spleen weights in dose-dependent fashion, and the slight increase in kidney weight, were observed in the i. p. ad ministered group ( In the i. p. treated mice, the incidence of histo pathological findings also showed a dose-dependent trend. Black granules, indicating InP, were ob served in the spleen, liver, lungs and lymph nodes. Small granulomas that included black granules were observed in the liver (Fig. 4) . The number of mice that showed extramedullary granulopoiesis of the liver significantly increased in the 5,000 mg/kg dosed group. In the alveoli, eosinophilic exudates were observed, and black granules and mononuclear cells, suggesting macrophages or type-II alveolar ep ithelial cells, were sometimes seen. The incidence significantly increased in the 3,000 and 5,000 mg/kg dosed groups. The spleen showed proliferation of granulocytes in the red pulp and decreased cellulari ty in the white pulp. Deposition of black granules and decreased cellularity were also observed in lymph nodes. No pathologically significant findings were observed in the kidney.
Hematological and serum biochemical findings
The results of hematological and serum biochemi cal examinations are shown in Table 3 . The pro portion of stab cells and monocytes was significant ly higher in the 5,000 mg/kg i. p. dosed group than in the control. 
Discussion
The LDLO of InP following i. p. or p. o. adminis tration was greater than 5,000 mg/kg, and the LD50 could not be calculated in this study. Compared with the LD50 of other indium compounds, such as indium trichloride (InC13) and indium nitrate (In (NO3)3), InP like metal indium4-6) was less toxic.
The main reason for its low lethal toxicity may be primarily the low solubility of InP in body fluids. As shown in Fig. 1 , InP was most soluble in syn thetic gastric solution, but its solubility was only 210 ug/ml as indium when maintained as InP powder at 37 C for 4 wks. Secondly, the low gas trointestinal absorption of indium has been reported by previous investigators who used some indium compounds' 11,12> These studies indicate that when indium is ingested, it has limited gastrointestinal ab sorption. The study by Zheng et al.') indicated that the sum of indium excreted in the urine and retain ed in the tissues accounted only for 0.67% of the dose administered at 24 hours after a single InP oral dose, and that the absorption process may serve as an amount-limited step for disposition of indium in the body following oral administration of InP. As a consequence, the low solubility of InP and/or poor absorption of InP may be the main reasons for the low lethal toxicity. The serum indium concentration increased ac cording to the InP dose, although its level was low. The body biological half-life (t1/2) of indium in mice receiving an intravenous injection of indium chloride has been reported to be 2 days for the fast phase component and 70 days for the slow-phase component13).
The urinary elimination t112 of indium in rats has been reported to be 32 hours, based on multiple oral administrations of InP7. Considering the previous reports and the current study together, the serum biological t1/2 in vivo may be 1 to 2 days. Studies on serum t1/2 are also needed.
InP was found to dissolve at a much slower rate in Gamble solution or in saline than in synthetic gastric fluid. This agrees with the results of Ditter and Fernando's study3). Since inhalation of InP in particulate form is possible in an industry environ ment such as a semiconductor factory, we should pay attention to the possibility of lung injury due to inhaling InP.
In the i. p. treated mice, the effects depended on the dose administered. The target organs of InP may be the lungs, liver, and spleen. High indium concentrations were detected in the liver. Black granules suggesting InP were also observed in the lymph nodes, liver, and spleen. The distributions suggest that the i.p. administered particles may be transferred to the spleen and liver by way of lympho kinetics, and may cause reticuloendothelial re sponses. A previous study indicated that InP parti cles in the lung may be removed by such a pathway as from the lungs to the liver via the reticuloendo thelial system, and from the liver to feces through extensive biliary excretion7).
Hydrated indium oxide, an insoluble metallic colloid, has been report ed to be cleared from the blood and accumulated in the reticuloendothelial system 14). Indium-treated silver disks implanted subcutaneously, intra muscularly and i. p. have been reported to induce only foreign-body reactions4). The reticuloendothe lial responses in the current study may also be ex plainable as reactions to foreign matter rather than the biological effects of InP itself. The proliferation of granulocytes in the red pulp and decreased cellu larity in the white pulp may be the exhaustion of immunocytes by phagocytosis for i. p. administra tion. Myeloid hematopoiesis in the liver and sple nomegaly (red pulp dominant) were based on the re action caused by the phagocytosis of foreign matter rather than by infection, because SPF animals were used, and because there were no findings in the organ supporting infection and no increase in WBC. An increase in the numbers of stab cells and mono cytes may be induced as a result of high production due to the consumption in the periphery.
A high indium concentration was also detected in the lungs, and black granules suggesting InP were seen in the alveoli. Although a red and partly dark red lung surface was observed in the macroscopic pathological findings, neither bleeding nor coagula tion was observed in the histopathological findings. But eosinophilic exudates and mononuclear cells, suggesting macrophages or type-II alveolar epitheli al cells, were observed in the alveoli. Inhalation by rats of indium oxide 4 hours daily for 3 months has been reported to result in an atypical pulmonary in flammation reaction 2). It is therefore possible that the red and partly dark red lung surface and eosin ophilic droplets in the alveoli may be the remainder of the inflammation. The particles suggesting InP in the alveoli and the reaction in the lung may also represent local responses caused by crumbling phag ocytes which phagocytized InP and were trapped in the lung.
It has been reported that hydrated indium oxide resulted in severe damage to hepatic parenchymal cells 14). In the current study, no severe damage to hepatic cells was observed histopathologically, al though small granulomas were shown. It is possible that the changes may cause the signicant increase in AST, which will require further study.
Renal histology, 24 hour post-injection of indium chloride, has been reported to show necrotic chang es in the convoluted tubules surrounding the glomeruli5). In the current study, there was no his topathological finding in the kidneys. Serum creat inine and BUN also showed no change related to toxicity. The toxic effect of InP on the kidneys seems to be less than that of other compound.
On the other hand, oral administration of InP did not show a clear relationship between dose and bio logical effects. This may be explained by the poor gastrointestinal absorption of InP7 .
It appears that follow-up studies should be im plemented to examine particle movement, serum t1/2, changes in bronchoalveolar lavage, and there should be pathological investigation after pulmo nary exposure under prolonged observation.
